Related Experiment Video

Updated: Jun 9, 2025

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
11:27

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

6.1K

Disorders of Coagulation in the Newborn

Lorena Ostilla1, Karyssa Knopoff2, Patrick Myers1

  • 1Section of Neonatology, Department of Pediatrics, Northwestern University, Chicago, IL.

Neoreviews
|October 31, 2024
PubMed

Insights

Neonatal coagulopathy, or infant bleeding disorders, presents unique challenges due to lower clotting factors. Early diagnosis and treatment are vital to reduce infant morbidity and mortality.

Area of Science:

  • Neonatal hemostasis and thrombosis
  • Pediatric hematology
  • Perinatal medicine

Background:

  • Newborn coagulation differs significantly from adults, with lower levels of key hemostatic factors.
  • Infants face unique risks from maternal conditions impacting their coagulation system.
  • Neonatal coagulopathy poses substantial risks for infant morbidity and mortality.

Purpose of the Study:

  • To provide a comprehensive overview of neonatal coagulopathy.
  • To detail clinical characteristics, diagnosis, and management strategies.
  • To review the epidemiology and etiologies of congenital and acquired forms.

Main Methods:

  • Literature review focusing on neonatal coagulopathy.
  • Synthesis of information on clinical presentations.
  • Analysis of diagnostic and management approaches.

Main Results:

  • Neonatal coagulopathy encompasses diverse congenital and acquired conditions.
  • Effective management requires understanding specific etiologies and clinical features.
  • Timely diagnosis is crucial for improving outcomes.

Conclusions:

  • Neonatal coagulopathy is a complex field requiring specialized knowledge.
  • This review serves as a resource for clinicians managing these disorders.
  • Further research can refine diagnostic and therapeutic strategies.

More Related Videos

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

2.8K
Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

693

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
716
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
624
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.8K
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
5.0K
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
821
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
873